Spencer E. Brightman

3 Patents

• US122687392025

  Use of Toll-like Receptor 2 (TLR-2) Agonist for Modulating Human Immune Response

  Dana-farber Cancer Institute, Inc.

  0 cites
• US117308102023

  Composition Comprising an Antigen and a Substituted Imidazo[1,2-a]pyrimidine for Enhancing Human Immune Response

  Dana-farber Cancer Institute, Inc.

  0 cites
• US116738912023

  Imidazopyrimidine Compounds and Uses Thereof

  Children's Medical Center Corporation

  0 cites